FDA Engagement Strategies And Best Practices Amid Agency Changes

How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies?

Should companies adjust their agency communication strategies or ask new questions during meetings? Our deeply experienced panelists will discuss key changes at the FDA, how companies can get the most out of agency interactions, and strategies to lower risks and avoid regulatory surprises.

Register for free today and secure your spot for this important virtual event.